Skip header and navigation

5 records – page 1 of 1.

Clinical handbook of psychotropic drugs

https://libcat.nshealth.ca/en/permalink/provcat42420
Ric M. Procyshyn, principal editor ; Kalyna Z. Bezchlibnyk-Butler, co-editor ; J. Joel Jeffries, co-editor. (22nd ed.) --Boston, MA: Hogrefe Publishing , c2017.
Call Number
QV 77 C641 2017 REF
Location
Nova Scotia Hospital
Cape Breton Regional
Aberdeen Hospital
Dickson Building
Halifax Infirmary
Sub-Location
REFERENCE
The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals. Independent, unbiased. Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions) for a quick overview of treatment options. Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactio…
Call Number
QV 77 C641 2017 REF
Other Authors
Procyshyn, Ric M.
Bezchlibnyk-Butler, Kalyna Z.
Jeffries, J. Joel
Responsibility
Ric M. Procyshyn, principal editor ; Kalyna Z. Bezchlibnyk-Butler, co-editor ; J. Joel Jeffries, co-editor
Edition
22nd ed.
Alternate Title
Psychotropic drugs
CHPD
Place of Publication
Boston, MA
Publisher
Hogrefe Publishing
Date of Publication
c2017
Physical Description
431 p.
ISBN
9781616764968
1616764961
Subjects (MeSH)
Psychotropic Drugs - administration and dosage
Psychotropic Drugs - therapeutic use
Abstract
The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals. Independent, unbiased. Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions) for a quick overview of treatment options. Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more - all you need to know for each class of drug. Potential interactions and side effects summarized in comparison charts. With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek. Clearly written patient information sheets available for download as printable PDF files.
Contents
Antidepressants -- Selective Serotonin Reuptake Inhibitors (SSRI) -- Norepinephrine Dopamine Reuptake Inhibitor (NDRI) -- Serotonin Norepinephrine Reuptake Inhibitor (SNRI) -- Serotonin-2 Antagonists/Reuptake Inhibitors (SARI) -- Serotonin-1A Agonist/Serotonin Reuptake Inhibitor -- Serotonin Stimulator/Serotonin Modulator -- Noradrenergic/Specific Serotonergic Antidepressants (NaSSA) -- Nonselective Cyclic Antidepressants -- Monoamine Oxidase Inhibitors -- Reversible Inhibitor of MAO-A (RIMA) -- Irreversible Monoamine Oxidase (A&B) Inhibitors (MAOIs) -- Irreversible MAO-B Inhibitor -- Effects of Antidepressants on Neurotransmitters/Receptors -- Pharmacological Effects of Antidepressants on Neurotransmitters/Receptors -- Frequency of Adverse Reactions to Antidepressants at Therapeutic Doses -- Antidepressant Doses and Pharmacokinetics -- Switching Antidepressants -- Antidepressant Augmentation Strategies -- Electroconvulsive Therapy (ECT) -- Bright Light Therapy (BLT) -- Repetitive Transcranial Magnetic Stimulation (rTMS) -- Antipsychotics -- "Second-Generation" Antipsychotics/SGAs -- "Third-Generation" Antipsychotic/TGA -- "First-Generation" Antipsychotics/FGAs -- Effects of Antipsychotics on Neurotransmitters/Receptors -- Pharmacological Effects of Antipsychotics on Neurotransmitters/Receptor Subtypes -- Relative Tolerability Profiles of Antipsychotics -- Frequency (%) of Adverse Reactions to Antipsychotics at Therapeutic Doses -- Antipsychotic Doses and Pharmacokinetics (Oral and Short-Acting Injections) -- Comparison of Long-Acting IM Antipsychotics -- Switching Antipsychotics -- Antipsychotic Augmentation Strategies -- Antipsychotic-Induced Extrapyramidal Side Effects and Their Management -- Extrapyramidal Adverse Effects of Antipsychotics -- Treatment Options for Extrapyramidal Side Effects -- Effects on Extrapyramidal Symptoms -- Comparison of Agents for Treating Acute Extrapyramidal Side Effects -- Doses and Pharmacokinetics of Agents for Treating Acute Extrapyramidal Side Effects -- Anxiolytic (Antianxiety) Agents -- Benzodiazepines -- Comparison of the Benzodiazepines -- Buspirone -- Hypnotics/Sedatives -- L-Tryptophan -- Comparison of Hypnotics/Sedatives -- Mood Stabilizers -- Lithium -- Anticonvulsants -- Comparison of Anticonvulsants -- Frequency of Adverse Reactions to Mood Stabilizers at Therapeutic Doses -- Drugs for ADHD -- Psychostimulants -- Atomoxetine -- Comparison of Drugs for ADHD -- a2 agonists -- Augmentation Strategies in ADHD -- Drugs for Treatment of Dementia -- Cholinesterase Inhibitors -- Memantine -- Comparison of Drugs for Treatment of Dementia -- Sex-Drive Depressants -- Comparison of Sex-Drive Depressants -- Drugs of Abuse -- Alcohol -- Stimulants -- Hallucinogens -- Opioids -- Inhalants/Aerosols -- Gamma-hydroxybutyrate (GHB)/Sodium Oxybate -- Flunitrazepam (Rohypnol) -- Nicotine/Tobacco -- Treatment of Substance Use Disorders -- Acamprosate -- Disulfiram -- Naltrexone -- Buprenorphine -- Methadone -- Pharmacotherapy for Nicotine/Tobacco Use Dependence -- Unapproved Treatments of Psychiatric Disorders -- Adrenergic Agents -- Dopaminergic Agents -- GABA Agents/Anticonvulsants -- Hormones -- NMDA Agents -- Miscellaneous -- Natural Health Products -- Ginkgo Biloba -- Inositol -- Kava Kava -- Melatonin -- Omega-3 Polyunsaturated Fatty Acids -- S-Adenosyl-L-methionine (SAMe) -- St. John's Wort -- Valerian -- Vitamins -- Pharmacogenomic Information for Common Psychotropic Drugs -- Antidepressants -- Antipsychotics -- Mood Stabilizers -- Drugs for Treatment of Dementia -- Opiate Receptor Ligands, Alcohol, Interferon -- Glossary -- Drug use in pregnancy and effects on breast milk -- Patient information sheets -- Appendix: Neuroscience-based nomenclature (NbN) -- Index of drugs.
Format
Book
Publication Type
Handbook
Location
Nova Scotia Hospital
Cape Breton Regional
Aberdeen Hospital
Dickson Building
Halifax Infirmary
Sub-Location
REFERENCE
Copies
5
Loan Period
In library use
Less detail

Clinical handbook of psychotropic drugs

https://libcat.nshealth.ca/en/permalink/provcat42494
Ric M. Procyshyn, principal editor ; Kalyna Z. Bezchlibnyk-Butler, co-editor ; J. Joel Jeffries, co-editor. (22nd ed.) --Boston, MA: Hogrefe Publishing , c2017.
Call Number
QV 77 C641 2017
Location
Yarmouth Regional Hospital
The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals. Independent, unbiased. Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions) for a quick overview of treatment options. Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactio…
Call Number
QV 77 C641 2017
Other Authors
Procyshyn, Ric M.
Bezchlibnyk-Butler, Kalyna Z.
Jeffries, J. Joel
Responsibility
Ric M. Procyshyn, principal editor ; Kalyna Z. Bezchlibnyk-Butler, co-editor ; J. Joel Jeffries, co-editor
Edition
22nd ed.
Alternate Title
Psychotropic drugs
CHPD
Place of Publication
Boston, MA
Publisher
Hogrefe Publishing
Date of Publication
c2017
Physical Description
431 p.
ISBN
9781616764968
1616764961
Subjects (MeSH)
Psychotropic Drugs - administration and dosage
Psychotropic Drugs - therapeutic use
Abstract
The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals. Independent, unbiased. Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions) for a quick overview of treatment options. Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more - all you need to know for each class of drug. Potential interactions and side effects summarized in comparison charts. With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek. Clearly written patient information sheets available for download as printable PDF files.
Contents
Antidepressants -- Selective Serotonin Reuptake Inhibitors (SSRI) -- Norepinephrine Dopamine Reuptake Inhibitor (NDRI) -- Serotonin Norepinephrine Reuptake Inhibitor (SNRI) -- Serotonin-2 Antagonists/Reuptake Inhibitors (SARI) -- Serotonin-1A Agonist/Serotonin Reuptake Inhibitor -- Serotonin Stimulator/Serotonin Modulator -- Noradrenergic/Specific Serotonergic Antidepressants (NaSSA) -- Nonselective Cyclic Antidepressants -- Monoamine Oxidase Inhibitors -- Reversible Inhibitor of MAO-A (RIMA) -- Irreversible Monoamine Oxidase (A&B) Inhibitors (MAOIs) -- Irreversible MAO-B Inhibitor -- Effects of Antidepressants on Neurotransmitters/Receptors -- Pharmacological Effects of Antidepressants on Neurotransmitters/Receptors -- Frequency of Adverse Reactions to Antidepressants at Therapeutic Doses -- Antidepressant Doses and Pharmacokinetics -- Switching Antidepressants -- Antidepressant Augmentation Strategies -- Electroconvulsive Therapy (ECT) -- Bright Light Therapy (BLT) -- Repetitive Transcranial Magnetic Stimulation (rTMS) -- Antipsychotics -- "Second-Generation" Antipsychotics/SGAs -- "Third-Generation" Antipsychotic/TGA -- "First-Generation" Antipsychotics/FGAs -- Effects of Antipsychotics on Neurotransmitters/Receptors -- Pharmacological Effects of Antipsychotics on Neurotransmitters/Receptor Subtypes -- Relative Tolerability Profiles of Antipsychotics -- Frequency (%) of Adverse Reactions to Antipsychotics at Therapeutic Doses -- Antipsychotic Doses and Pharmacokinetics (Oral and Short-Acting Injections) -- Comparison of Long-Acting IM Antipsychotics -- Switching Antipsychotics -- Antipsychotic Augmentation Strategies -- Antipsychotic-Induced Extrapyramidal Side Effects and Their Management -- Extrapyramidal Adverse Effects of Antipsychotics -- Treatment Options for Extrapyramidal Side Effects -- Effects on Extrapyramidal Symptoms -- Comparison of Agents for Treating Acute Extrapyramidal Side Effects -- Doses and Pharmacokinetics of Agents for Treating Acute Extrapyramidal Side Effects -- Anxiolytic (Antianxiety) Agents -- Benzodiazepines -- Comparison of the Benzodiazepines -- Buspirone -- Hypnotics/Sedatives -- L-Tryptophan -- Comparison of Hypnotics/Sedatives -- Mood Stabilizers -- Lithium -- Anticonvulsants -- Comparison of Anticonvulsants -- Frequency of Adverse Reactions to Mood Stabilizers at Therapeutic Doses -- Drugs for ADHD -- Psychostimulants -- Atomoxetine -- Comparison of Drugs for ADHD -- a2 agonists -- Augmentation Strategies in ADHD -- Drugs for Treatment of Dementia -- Cholinesterase Inhibitors -- Memantine -- Comparison of Drugs for Treatment of Dementia -- Sex-Drive Depressants -- Comparison of Sex-Drive Depressants -- Drugs of Abuse -- Alcohol -- Stimulants -- Hallucinogens -- Opioids -- Inhalants/Aerosols -- Gamma-hydroxybutyrate (GHB)/Sodium Oxybate -- Flunitrazepam (Rohypnol) -- Nicotine/Tobacco -- Treatment of Substance Use Disorders -- Acamprosate -- Disulfiram -- Naltrexone -- Buprenorphine -- Methadone -- Pharmacotherapy for Nicotine/Tobacco Use Dependence -- Unapproved Treatments of Psychiatric Disorders -- Adrenergic Agents -- Dopaminergic Agents -- GABA Agents/Anticonvulsants -- Hormones -- NMDA Agents -- Miscellaneous -- Natural Health Products -- Ginkgo Biloba -- Inositol -- Kava Kava -- Melatonin -- Omega-3 Polyunsaturated Fatty Acids -- S-Adenosyl-L-methionine (SAMe) -- St. John's Wort -- Valerian -- Vitamins -- Pharmacogenomic Information for Common Psychotropic Drugs -- Antidepressants -- Antipsychotics -- Mood Stabilizers -- Drugs for Treatment of Dementia -- Opiate Receptor Ligands, Alcohol, Interferon -- Glossary -- Drug use in pregnancy and effects on breast milk -- Patient information sheets -- Appendix: Neuroscience-based nomenclature (NbN) -- Index of drugs.
Format
Book
Publication Type
Handbook
Location
Yarmouth Regional Hospital
Loan Period
3 weeks use
Less detail

Clinical handbook of psychotropic drugs

https://libcat.nshealth.ca/en/permalink/provcat45175
editors, Ric M. Procyshyn, Kalyna Z. Bezchlibnyk-Butler, and J. Joel Jeffries. (23rd ed.) --Boston, MA: Hogrefe Publishing , c2019.
Available Online
View e-Book
Location
Online
The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals. It is independent, unbiased, and packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options.
Available Online
View e-Book
Other Authors
Procyshyn, Ric M.
Bezchlibnyk-Butler, Kalyna Z.
Jeffries, J. Joel
Responsibility
editors, Ric M. Procyshyn, Kalyna Z. Bezchlibnyk-Butler, and J. Joel Jeffries
Edition
23rd ed.
Alternate Title
Psychotropic drugs
CHPD
Place of Publication
Boston, MA
Publisher
Hogrefe Publishing
Date of Publication
c2019
Physical Description
1 online resource
ISBN
9781616765613
Subjects (MeSH)
Psychotropic Drugs - administration and dosage
Psychotropic Drugs - therapeutic use
Specialty
Pharmacy
Psychiatry
Abstract
The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals. It is independent, unbiased, and packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options.
Format
e-Book
Publication Type
Handbook
Location
Online
Less detail

Clinical handbook of psychotropic drugs for children and adolescents online

https://libcat.nshealth.ca/en/permalink/provcat50510
(4th ed.) Hogrefe Publishing , 2021.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Edition
4th ed.
Publisher
Hogrefe Publishing
Date of Publication
2021
Subjects (MeSH)
Psychotropic Drugs - administration and dosage
Psychotropic Drugs - therapeutic use
Child
Adolescent
Notes
Access to this online resource is restricted to IWK Health Centre employees working from inside the hospital network.
Format
e-Book
Location
Online
Less detail

Clinical handbook of psychotropic drugs online

https://libcat.nshealth.ca/en/permalink/provcat50511
(24th ed.) Hogrefe Publishing , 2021.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Edition
24th ed.
Publisher
Hogrefe Publishing
Date of Publication
2021
ISBN
9781616765613 (print)
9780889375505 (print)
Subjects (MeSH)
Psychotropic Drugs - administration and dosage
Psychotropic Drugs - therapeutic use
Notes
Access to this online resource is restricted to IWK Health Centre employees working from inside the hospital network.
Format
e-Book
Location
Online
Less detail